We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




High Resolution Gene Mapping Validates Integrity of Stem Cell Genomes

By LabMedica International staff writers
Posted on 03 Feb 2010
Researchers working with human embryonic stem cells and other types of pluripotent stem cells that grow in cell cultures for extended periods of time will benefit from a gene mapping service that offers high resolution monitoring of the genome at a cost comparable to traditional karyotyping.

Ambry Genetics (Aliso Viejo, CA, USA), a company specializing in genetic testing, has introduced their StemArray service. More...
StemArray, which is based on array comparative genomic hybridization (aCGH) technology, offers higher resolution (44 K) gene mapping as compared to the five MB for standard karyotyping.

This higher resolution allows the detection of smaller duplications and deletions with the possibility of single gene resolution in pluripotent and cancer associated regions. The service has a turnaround time of two weeks, and pricing is comparable to karyotyping cost.

"As human stem cells begin to make their way into clinical studies, it is essential that the cell lines be thoroughly characterized," said Dr. Aaron Elliott, head of genomics research and development at Ambry Genetics. "Using the StemArray scientists will not only detect the extremely large copy number changes that can be found by karyotype, but also identify very small aberrations that occur during culture that could decrease the reproducibility and reliability of experimental data."

Related Links:

Ambry Genetics



New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Multi-Chamber Washer-Disinfector
WD 390
New
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The method that profiles DNA methylation in cell-free DNA from a single blood sample to detect disease signals system-wide (photo courtesy of Shutterstock)

cfDNA Methylation Assay Enables Multi-Disease Detection from Single Blood Sample

Early, accurate detection of cancer and organ disease remains limited by cost, reliance on targeted mutation assays, and uncertainty about the signal’s tissue of origin. Many liquid biopsy approaches require... Read more

Immunology

view channel
Image: Mycobacterium tuberculosis bacteria seen with a scanning electron microscope (Credit: CDC PHIL)

Antibody Blood Test Identifies Active TB and Distinguishes Latent Infection

Active tuberculosis (TB) remains a leading cause of death and illness worldwide, yet distinguishing contagious disease from latent infection continues to challenge clinicians. Standard screening tools... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.